Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide versus metformin in overweight/obese women with polycystic ovary syndrome
ChiCTR2500105880Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirzepatide in polycystic ovary syndrome (PCOS), Overweight and obesity (3 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Body mass index (BMI), Waist-to-hip ratio and 1 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
03
Conditions
polycystic ovary syndrome (PCOS)Overweightobesity
Beyond the preview
Go deeper on ChiCTR2500105880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105880.